Kindred Bio IPO Ushers in New Industry

Biotechnology and veterinary medicine intersect to create an emerging new industry as the hot IPO market continues. TroyGould members Sandy Hillsberg and Dale Short are leading the team handling the initial public offering by Kindred Biosciences, Inc. Other team members include member Marc Brown and associate Dietrick Miller. Lead underwriters BMO Capital Markets and Guggenheim Partners are represented by Latham & Watkins LLP., Costa Mesa, California. The Latham team includes partners Charles K. Ruck and B. Shayne Kennedy and associate Nicholas M. Look.